OCT-based, objective detection of IOL glistenings

Technology
In development
University
Scouted & summarized by Halo AI

Heidelberg University has developed an objective, examiner-independent method to analyze glistenings in hydrophobic acrylic intraocular lenses using swept-source optical coherence tomography (SS-OCT). By employing machine-learning-based image processing to quantify microvacuoles, this research-validated approach provides a precise alternative to subjective clinical assessments, enabling accurate estimation of straylight and glare symptoms in patients.

Overview

This research-based artifact is an objective, examiner-independent method for analyzing glistenings—small, refractile microvacuoles that can form within hydrophobic acrylic intraocular lenses (IOLs) and potentially reduce a patient's visual quality. By utilizing swept-source optical coherence tomography (SS-OCT), this method provides a precise, reproducible way to quantify glistening density and estimate the resulting straylight, offering a significant improvement over traditional, subjective clinical assessments like slit-lamp examinations.

Technical specifications
  • Technology: Swept-source optical coherence tomography (SS-OCT) combined with automated image-processing software.
  • Methodology: The approach uses a custom-built IOL holder for in-vitro examination, allowing for precise B-scan acquisition. Image analysis is performed using the Fiji toolkit with the Trainable Weka Segmentation (TWS) plugin, a machine-learning-based pixel classifier that automatically segments and counts glistenings (hyper-reflective foci) within the IOL optic.
  • Performance: The method demonstrates a strong, proportional relationship (R2 = 0.91) with established in-vitro light microscopy reference methods and a moderate correlation with straylight measurements, enabling clinicians to objectively estimate glare symptoms in pseudophakic patients.
Technology readiness level

This method is currently at a research and validation stage (TRL 4-5). It has been successfully demonstrated in-vitro using multiple IOL models and compared against established reference standards. While the research indicates potential for future clinical implementation—including the possibility of a built-in application for scatterer evaluation—it is primarily documented as a validated experimental methodology rather than a commercialized product.

Generated Oct 8, 2026. Please verify key information.

About Heidelberg University

Heidelberg University is a large, comprehensive public research university in southwest Germany with a strong international profile and an integrated academic medical center. For industry partners it offers access to hospital-based clinical research, shared core facilities, and co-located national research organizations that enable rapid validation. The campus links to a mature research and technology park and regional incubators, providing space for joint labs, pilots, and collaboration with startups and established companies in the Rhine‑Neckar economy. Research is backed by competitive funding from the German Research Foundation, federal ministries, and European Union programs. A dedicated technology transfer office manages IP, licensing, sponsored research agreements, and spin‑off pathways.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.